StockData
Teva Pharmaceutical Industries Ltd logo

Teva Pharmaceutical Industries Ltd (TEVA) stock

TEVANYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/30127% above fair value
$42.57−1.93 (-4.34%)

Close on Nov 16, 2026Market cap $49.61BP/E 71.0Yield –

Teva Pharmaceutical Industries market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Teva Pharmaceutical Industries's market cap was $49.61B on Nov 10, 2026, against $31.04B a year earlier. Over the last 5 years it ranged from $8.02B to $49.61B, with a median of $17.54B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 10, 2026$49.61B+37.7%
2025Dec 31, 2025$36.03B+45.1%
2024Dec 31, 2024$24.84B+112.3%
2023Dec 29, 2023$11.70B+15.7%
2022Dec 30, 2022$10.12B+14.3%
2021Dec 31, 2021$8.85B-16.3%
2020Dec 31, 2020$10.57B+0.4%
2019Dec 31, 2019$10.53B-32.9%
2018Dec 31, 2018$15.70B-49.2%
2017Jan 31, 2017$30.92B-7.8%
2016Dec 30, 2016$33.53B-40.6%
2015Dec 31, 2015$56.47B+14.9%
2014Dec 31, 2014$49.13B+43.4%
2013Dec 31, 2013$34.25B+4.6%
2012Dec 31, 2012$32.75B-10.1%
2011Dec 30, 2011$36.41B-25.4%
2010Dec 31, 2010$48.79B-5.5%
2009Dec 31, 2009$51.63B–

More Teva Pharmaceutical Industries figures

See a number that looks wrong?